Buscar resultados de ensayos clínicos
Ovarian Carcinosarcoma - 20 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26 Condición:
Fecha: 2016-12-01 Intervenciones: Drug: Trabectedin Other Name: Yondelis |
Not yet recruiting |
Nombre del estudio: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer Condición:
|
Not yet recruiting |
Nombre del estudio: Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Condición:
Fecha: 2009-08-06 Intervenciones: |
Recruiting |
Nombre del estudio: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condición:
|
Completed |
Nombre del estudio: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma Condición:
|
Completed |
Nombre del estudio: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Condición:
|
Active, not recruiting |
Nombre del estudio: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Condición:
|
Completed |
Nombre del estudio: Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer Condición:
|
Recruiting |
Nombre del estudio: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers Condición:
|
Active, not recruiting |
Nombre del estudio: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Condición:
|